These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 15498797)

  • 1. Primary Sjögren's syndrome: new clinical and therapeutic concepts.
    Ramos-Casals M; Tzioufas AG; Font J
    Ann Rheum Dis; 2005 Mar; 64(3):347-54. PubMed ID: 15498797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of patients presenting with Sjogren's syndrome.
    Venables PJ
    Best Pract Res Clin Rheumatol; 2006 Aug; 20(4):791-807. PubMed ID: 16979538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Sjögren's syndrome: a new approach to treatment].
    Rossier V; Bart PA; Spertini F
    Rev Med Suisse; 2012 Apr; 8(337):843-7. PubMed ID: 22594008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the treatment of Sjögren's syndrome.
    Fox RI; Michelson P
    J Rheumatol Suppl; 2000 Dec; 61():15-21. PubMed ID: 11128699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary Sjögren's Syndrome.
    Mariette X; Criswell LA
    N Engl J Med; 2018 Mar; 378(10):931-939. PubMed ID: 29514034
    [No Abstract]   [Full Text] [Related]  

  • 6. The management of Sjögren's syndrome.
    Mavragani CP; Moutsopoulos NM; Moutsopoulos HM
    Nat Clin Pract Rheumatol; 2006 May; 2(5):252-61. PubMed ID: 16932698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.
    Brito-Zerón P; Ramos-Casals M;
    Curr Opin Rheumatol; 2014 Sep; 26(5):520-7. PubMed ID: 25050925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sjögren's syndrome patients presenting with hypergammaglobulinemia are relatively unresponsive to cevimeline treatment.
    Komai K; Shiozawa K; Tanaka Y; Yoshihara R; Tanaka C; Sakai H; Yamane T; Murata M; Tsumiyama K; Hashiramoto A; Shiozawa S
    Mod Rheumatol; 2009; 19(4):416-9. PubMed ID: 19452244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of muscarinic agonists in the treatment of Sjögren's syndrome.
    Fox RI; Konttinen Y; Fisher A
    Clin Immunol; 2001 Dec; 101(3):249-63. PubMed ID: 11726216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sjögren's syndrome: dental considerations.
    Singh M; Palmer C; Papas AS
    Dent Today; 2010 May; 29(5):64, 66-7; quiz 67. PubMed ID: 20506911
    [No Abstract]   [Full Text] [Related]  

  • 11. [Sjogren's syndrome].
    Rasković S; Bogić M; Perić-Popadić A; Tomić-Spirić V
    Srp Arh Celok Lek; 1997; 125(1-2):54-8. PubMed ID: 17974357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progress and regression within primary Sjögren's syndrome.
    Manthorpe R; Bredberg A; Henriksson G; Larsson A
    Scand J Rheumatol; 2006; 35(1):1-6. PubMed ID: 16467033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The therapy of Sjogren's syndrome: a review.
    Coaccioli S; Giuliani M; Puxeddu A
    Clin Ter; 2007; 158(5):453-6. PubMed ID: 18062353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is Sjögren's syndrome and why is it important?
    Talal N
    J Rheumatol Suppl; 2000 Dec; 61():1-3. PubMed ID: 11128697
    [No Abstract]   [Full Text] [Related]  

  • 15. Primary Sjogren's syndrome: current and prospective therapies.
    Thanou-Stavraki A; James JA
    Semin Arthritis Rheum; 2008 Apr; 37(5):273-92. PubMed ID: 17714766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Articular manifestations of primary Sjögren's syndrome.
    Castro-Poltronieri A; Alarcón-Segovia D
    J Rheumatol; 1983 Jun; 10(3):485-8. PubMed ID: 6887174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment with intravenous immunoglobulin of severe thrombocytopenia complicated in primary Sjögren's syndrome.
    Choung BS; Yoo WH
    Rheumatol Int; 2012 May; 32(5):1353-5. PubMed ID: 20237930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sjögren's syndrome: diagnosis and systemic manifestations].
    Hatron PY
    Rev Prat; 2012 Feb; 62(2):221-4. PubMed ID: 22408869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of extraglandular manifestations of Sjögren's syndrome.
    Cheah TE; Jasmin R; Sockalingam S
    Int J Rheum Dis; 2012 Dec; 15(6):e156-8. PubMed ID: 23253245
    [No Abstract]   [Full Text] [Related]  

  • 20. Xerostomia secondary to Sjögren's syndrome in the elderly: recognition and management.
    Al-Hashimi I
    Drugs Aging; 2005; 22(11):887-99. PubMed ID: 16323968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.